EVOPROG is an EU FET-Proactive consortium devoted to developing new technology to engineer molecules based on bacteriophages (phages), continuous cultures and evolution.
EVOPROG exemplifies the usefulness of novel technologies and approaches to engineer phages, which could transform phage therapy as we know it today.
The focus of this EVOPROG conference is to encourage new interdisciplinary approaches based on phages to fight Antimicrobial Resistance (AMR).
The conference will facilitate discussions between specialists who have expertise in phages, virology, directed evolution, microbiology & microbial diversity and encourage collaborations to tackle AMR.
Our goal is to provide an innovative interface for directed evolutionary technologies and antimicrobial resistance, to foster learning, inspiration and wonder – and provoke conversations that matter.
In the age of genome sequencing and engineering, new emerging technologies can be used to design novel antimicrobial strategies:
1) Enhance existing antibiotics.
2) Alternative antimicrobials such as molecules derived from phages.
3) Synthetic phages or phage-like particles as antimicrobials.